These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14535588)

  • 1. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
    Kim SB; Fernandes LC; Saad SS; Matos D
    Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
    Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
    Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
    Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
    Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.
    Fernandes LC; Kim SB; Matos D
    World J Gastroenterol; 2005 Feb; 11(5):645-8. PubMed ID: 15655814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait.
    Behbehani AI; Al-Sayer H; Farghaly M; Kanawati N; Mathew A; al-Bader A; Van Dalen A
    Int J Biol Markers; 2000; 15(1):51-5. PubMed ID: 10763141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
    Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
    Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Huh JW; Kim CH; Lim SW; Kim HR; Kim YJ
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1449-55. PubMed ID: 23765330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
    Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour marker CA 195 in colorectal and pancreatic cancer.
    Sagar PM; Taylor OM; Cooper EH; Benson EA; McMahon MJ; Finan PJ
    Int J Biol Markers; 1991; 6(4):241-6. PubMed ID: 1795132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas.
    Yedema CA; Kenemans P; Wobbes T; Thomas CM; Bon GG; Mulder C; Voorhorst FJ; Verstraeten AA; van Kamp GJ; Hilgers J
    Tumour Biol; 1992; 13(1-2):18-26. PubMed ID: 1589694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.